_version_ 1785090753654947840
author Martinez, Celia
Gutiérrez, Paola Villafuerte
Galina, Motornaya
Gómez, Maria Barbaño Acevedo
Fernández, Juan Jose Gil
Cilleruelo, Jose Maria Aspa
Garcia, Lucia Castilla
Marina, Maria Argüello
de Hontanar, Guzman López
Barquero, Pedro Antonio Rodríguez
Paula, Gili Herreros
Marta, Callejas Charavia
Isabel, Gutierrez Jomarrón
Elena, Magro Mazo
Cristina, San Andrés Corral
Suarez, Julio García
author_facet Martinez, Celia
Gutiérrez, Paola Villafuerte
Galina, Motornaya
Gómez, Maria Barbaño Acevedo
Fernández, Juan Jose Gil
Cilleruelo, Jose Maria Aspa
Garcia, Lucia Castilla
Marina, Maria Argüello
de Hontanar, Guzman López
Barquero, Pedro Antonio Rodríguez
Paula, Gili Herreros
Marta, Callejas Charavia
Isabel, Gutierrez Jomarrón
Elena, Magro Mazo
Cristina, San Andrés Corral
Suarez, Julio García
author_sort Martinez, Celia
collection PubMed
description
format Online
Article
Text
id pubmed-10429593
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104295932023-08-17 PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE Martinez, Celia Gutiérrez, Paola Villafuerte Galina, Motornaya Gómez, Maria Barbaño Acevedo Fernández, Juan Jose Gil Cilleruelo, Jose Maria Aspa Garcia, Lucia Castilla Marina, Maria Argüello de Hontanar, Guzman López Barquero, Pedro Antonio Rodríguez Paula, Gili Herreros Marta, Callejas Charavia Isabel, Gutierrez Jomarrón Elena, Magro Mazo Cristina, San Andrés Corral Suarez, Julio García Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429593/ http://dx.doi.org/10.1097/01.HS9.0000977160.45965.df Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Martinez, Celia
Gutiérrez, Paola Villafuerte
Galina, Motornaya
Gómez, Maria Barbaño Acevedo
Fernández, Juan Jose Gil
Cilleruelo, Jose Maria Aspa
Garcia, Lucia Castilla
Marina, Maria Argüello
de Hontanar, Guzman López
Barquero, Pedro Antonio Rodríguez
Paula, Gili Herreros
Marta, Callejas Charavia
Isabel, Gutierrez Jomarrón
Elena, Magro Mazo
Cristina, San Andrés Corral
Suarez, Julio García
PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
title PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
title_full PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
title_fullStr PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
title_full_unstemmed PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
title_short PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
title_sort pb2618: use and discontinuation of thrombopoietin receptor agonists in patients with immune thrombocytopenia: a single centre experience
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429593/
http://dx.doi.org/10.1097/01.HS9.0000977160.45965.df
work_keys_str_mv AT martinezcelia pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT gutierrezpaolavillafuerte pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT galinamotornaya pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT gomezmariabarbanoacevedo pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT fernandezjuanjosegil pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT cilleruelojosemariaaspa pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT garcialuciacastilla pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT marinamariaarguello pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT dehontanarguzmanlopez pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT barqueropedroantoniorodriguez pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT paulagiliherreros pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT martacallejascharavia pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT isabelgutierrezjomarron pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT elenamagromazo pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT cristinasanandrescorral pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience
AT suarezjuliogarcia pb2618useanddiscontinuationofthrombopoietinreceptoragonistsinpatientswithimmunethrombocytopeniaasinglecentreexperience